Nav: Home

Breast cancer cells rely on pyruvate to expand in new tissues

March 04, 2019

Most patients who die of breast cancer die of metastasis, the process by which cancer cells spread to other organs of the body. Cancer cells alter their metabolism to grow and expand across other organs. A new study by Prof. Sarah-Maria Fendt from the VIB-KU Leuven Center for Cancer Biology and her PhD student Ilaria Elia has shown that breast cancer cells require the nutrient pyruvate to do this.

When cancer cells spread to different organs, and in particular to the lungs, they first need to reshape the healthy lung environment into a so-called metastatic niche that supports the growth of cancer cells. The enzyme that cancer cells need to activate this process is called collagen prolyl 4 hydroxylase. Until now, it was believed that the activity of this enzyme is regulated in both cancer and healthy cells by the amount of enzyme present. In other words, it is thought that if a lot of the enzyme is present its activity is high and vice versa. Since collagen prolyl 4 hydroxylase also has important functions in healthy cells, collagen prolyl 4 hydroxylase is a difficult cancer drug target because this would target cancer as well as healthy cells.

Prof. Sarah-Maria Fendt from the VIB-KU Leuven Center for Cancer Biology and her PhD student Ilaria Elia have now discovered that breast cancer cells that reach the lung require the nutrient pyruvate to restructure the healthy lung environment so that cancer cells can grow into metastasis. Specifically, pyruvate drives the production of a small molecule called α-ketoglutarate. This small molecule regulates the activity of collagen prolyl 4 hydroxylase independently of the amount of this enzyme. Importantly, only cancer cells or cells supporting the spread of cancer cells to distant organs seem to rely on this pyruvate-dependent mechanism to create a pro-tumor environment in the lung. This means that inhibiting pyruvate uptake by breast cancer cells, is sufficient to greatly impair metastasis formation in different breast cancer mouse models.

Interestingly, in an independent study Prof. Geert Carmeliet and Dr. Steve Stegen (Lab of Clinical and Experimental Endocrinology, KU Leuven) have investigated how normal bone cells create a healthy environment using collagen prolyl 4 hydroxylase. They found that bone cells also require α-ketoglutarate to regulate the activity of collagen prolyl 4 hydroxylase resulting in normal bone development and regeneration. But differently to cancer cells, normal bone cells do not rely on pyruvate, but the nutrient glutamine for this important function. Currently, mouse models already exist to target cancer cells without harming healthy cells and vice versa by selectively changing the uptake of pyruvate or glutamine.

Overall, these two studies indicate that healthy and cancer cells use different nutrients to shape their environment. This novel insight can be used to develop new therapies that specifically target breast cancer cells that have spread to the lung, while sparing healthy cells.
-end-


VIB (the Flanders Institute for Biotechnology)

Related Cancer Articles:

Radiotherapy for invasive breast cancer increases the risk of second primary lung cancer
East Asian female breast cancer patients receiving radiotherapy have a higher risk of developing second primary lung cancer.
Cancer genomics continued: Triple negative breast cancer and cancer immunotherapy
Continuing PLOS Medicine's special issue on cancer genomics, Christos Hatzis of Yale University, New Haven, Conn., USA and colleagues describe a new subtype of triple negative breast cancer that may be more amenable to treatment than other cases of this difficult-to-treat disease.
Metabolite that promotes cancer cell transformation and colorectal cancer spread identified
Osaka University researchers revealed that the metabolite D-2-hydroxyglurate (D-2HG) promotes epithelial-mesenchymal transition of colorectal cancer cells, leading them to develop features of lower adherence to neighboring cells, increased invasiveness, and greater likelihood of metastatic spread.
UH Cancer Center researcher finds new driver of an aggressive form of brain cancer
University of Hawai'i Cancer Center researchers have identified an essential driver of tumor cell invasion in glioblastoma, the most aggressive form of brain cancer that can occur at any age.
UH Cancer Center researchers develop algorithm to find precise cancer treatments
University of Hawai'i Cancer Center researchers developed a computational algorithm to analyze 'Big Data' obtained from tumor samples to better understand and treat cancer.
New analytical technology to quantify anti-cancer drugs inside cancer cells
University of Oklahoma researchers will apply a new analytical technology that could ultimately provide a powerful tool for improved treatment of cancer patients in Oklahoma and beyond.
Radiotherapy for lung cancer patients is linked to increased risk of non-cancer deaths
Researchers have found that treating patients who have early stage non-small cell lung cancer with a type of radiotherapy called stereotactic body radiation therapy is associated with a small but increased risk of death from causes other than cancer.
Cancer expert says public health and prevention measures are key to defeating cancer
Is investment in research to develop new treatments the best approach to controlling cancer?
UI Cancer Center, Governors State to address cancer disparities in south suburbs
The University of Illinois Cancer Center and Governors State University have received a joint four-year, $1.5 million grant from the National Cancer Institute to help both institutions conduct community-based research to reduce cancer-related health disparities in Chicago's south suburbs.
Leading cancer research organizations to host international cancer immunotherapy conference
The Cancer Research Institute, the Association for Cancer Immunotherapy, the European Academy of Tumor Immunology, and the American Association for Cancer Research will join forces to sponsor the first International Cancer Immunotherapy Conference at the Sheraton New York Times Square Hotel in New York, Sept.

Related Cancer Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Setbacks
Failure can feel lonely and final. But can we learn from failure, even reframe it, to feel more like a temporary setback? This hour, TED speakers on changing a crushing defeat into a stepping stone. Guests include entrepreneur Leticia Gasca, psychology professor Alison Ledgerwood, astronomer Phil Plait, former professional athlete Charly Haversat, and UPS training manager Jon Bowers.
Now Playing: Science for the People

#524 The Human Network
What does a network of humans look like and how does it work? How does information spread? How do decisions and opinions spread? What gets distorted as it moves through the network and why? This week we dig into the ins and outs of human networks with Matthew Jackson, Professor of Economics at Stanford University and author of the book "The Human Network: How Your Social Position Determines Your Power, Beliefs, and Behaviours".